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Abstract 
Background: The stellate ganglion (SG) is important for cardiac autonomic control. SG 
modification is an option for treating refractory ventricular tachyarrhythmias. The optimal 
extent of left- and right-sided SG denervation necessary for antiarrhythmic effect, 
however, remains to be learned.  
Objective: To evaluate the effects of stepwise SG denervation on hemodynamic and 
electrophysiologic parameters in dogs. 
Methods: After sequential left and right thoracotomy in 8 healthy dogs, the SG was 
exposed by dissection. Two pacing wires were placed in the upper SG to deliver high-
frequency stimulation. The lower SG, ansae subclaviae, and upper SG were removed in 
a stepwise manner. The same protocol was performed on the right side. Blood pressure 
(BP), heart rate, and electrophysiologic parameters were recorded at baseline and after 
5 minutes of stimulation.  
Results: Systolic and diastolic BP significantly increased during upper left SG 
stimulation. Mean increase in systolic BP from baseline was 49.4 (26.6) mm Hg 
(P=.007), 25.5 (14.1) mm Hg after the lower SG was removed (P=.02), and 8.6 (3.4) 
mm Hg after resection of the ipsilateral ansae subclaviae (P=.048). Heart rate and other 
electrophysiologic parameters did not change significantly. After complete removal of 
the left SG, the systolic BP increased 34.0 (17.6) mm Hg (P=.005) after stimulation of 
the right SG. 
Conclusions: Sympathetic output remains after the lower SG is removed, and 
sympathetic output from the right SG remains after complete resection of the left SG 
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and ansae subclaviae. Thus, some patients who undergo left SG denervation can still 
have significant sympathetic response via right SG regulation. 
Key Words: ansa subclavia; canine; cardiac sympathetic denervation; stellate ganglion; 
vagal trunk   
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Abbreviations 
BP, blood pressure  
CSD, cardiac sympathetic denervation  
ERP, effective refractory period 
HR, heart rate    
LSG, left side of the SG  
LV, left ventricle  
RSG, right side of the SG  
SG, stellate ganglion   
VF, ventricular fibrillation 
VT, ventricular tachyarrhythmia  
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Introduction 
The heart is richly innervated by autonomic nerves. The balance between the 
parasympathetic and sympathetic effects of the autonomic nervous system has an 
important role in proper cardiac function.1 Both aspects of the autonomic nervous 
system have significant effects on cardiac chronotropy and inotropy.2 The stellate 
ganglion (SG) provides important sympathetic nerve inputs into the heart and may 
predispose the myocardial conduction system and myocardium itself to multiple types of 
atrial and ventricular arrhythmias.3  
Cardiac sympathetic denervation (CSD) has been shown to reduce the burden of 
ventricular arrhythmias acutely.4 Preganglionic sympathetic efferents arising from the 
T1-T4 spinal cord that project to the heart transit through stellate ganglia via the 
paravertebral chain. In left-sided CSD procedures, the lower half (T1-T4) of the left side 
of the SG (LSG) is removed.5 A recent work by Buckley and Ardell showed that T1-T2 
surgical excision is sufficient to functionally interrupt central control of peripheral 
sympathetic efferent activity.6  However, the upper part of T1 of the LSG and ansae 
subclaviae remain connected to the heart and can still affect cardiac function through 
these remaining sympathetic innervations. Studies defining the role of the remaining 
segments after left CSD are scarce. Furthermore, the balance between the sympathetic 
and parasympathetic nervous systems is dynamic and is altered after left CSD 
procedures. Thus, we investigated the effects of stepwise SG denervation with 
subsequent stimulation of the remaining nerve tissue in dogs to assess the physiologic 
effects on blood pressure (BP), heart rate (HR), and electrophysiologic intervals. 
Methods 
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Animal Preparation and Anesthesia 
The study were approved by the Mayo Clinic Institutional Animal Care and Use 
Committee and performed under the guidelines of the National Institutes of Health 
Guide for the Care and Use of Animals. 8 male mongrel dogs (weight, 30-40 kg) were 
anesthetized with ketamine/diazepam for induction and intubation, and intravenous 
isoflurane (1%-3%) and propofol (7-15 mg/kg per min) were used to provide adequate 
anesthesia during nerve stimulation, as well as for maintenance of an adequate 
anesthetic plane during thoracotomy to access the nervous structures. After 
visualization of these structures, isoflurane was reduced to the lowest level possible, 
and propofol was increased to maintain adequate anesthesia. This was done to allow 
for adequate evaluation of the sympathetic system during stimulation testing, because 
propofol has less effect on autonomic tone than isoflurane.7, 8 
HR and heart rhythm were monitored continuously throughout the study. BP was 
monitored continuously via a femoral arterial line and was recorded at 15-minute 
intervals when not measured as part of the stimulation aspect of the study. Core body 
temperature was monitored and maintained euthermic throughout the study. Vascular 
access was obtained percutaneously, and sheaths were placed using an over-the-wire 
technique. Femoral veins, arteries, and external jugular veins were used for placement 
of 9 to 12 F sheaths for access for the monitoring and stimulation electrodes.  
Catheter Placement for Electrophysiologic Study 
A Boston Scientific XPT Blazer II Catheter (8 F, 4-mm tip, 2.5-mm electrode 
spacing) was placed at the right ventricular apex for both ventricular recording and 
stimulation. A multipolar catheter (CS catheter, 6F; Biosense Webster) was inserted into 
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the internal jugular vein and placed in the coronary sinus under fluoroscopic guidance 
(Axiom artis dTA; Siemens Inc). Electrocardiography, arterial BP, and multichannel 
intracardiac electrograms were continuously stored using the Prucka CardioLab 
recording system (GE Healthcare). 
Electrophysiology parameters were collected from the Prucka system using 
coronary sinus and ventricular recording catheters. These included the PR, QRS, and 
QT intervals. Pacing from the coronary sinus and right ventricle was done using a 
Bloom Stimulator (Fischer Medical Technologies LLC). The atrial and ventricular 
effective refractory periods (ERPs) were determined by pacing the left atrium and right 
ventricle, noting the refractory period from a drive train of 8 pulses with a subsequent 
early S2 stimulus at twice the pacing threshold of the tissue. The left atrial conduction 
time was taken as the time for signal travel from the distal to proximal coronary sinus 
when the left atrium was captured. The left ventricular (LV) conduction time was 
determined as the traveling time from distal to proximal coronary sinus when the LV was 
captured.  
Approach to Thoracotomy and Nerve Dissection 
The methods of thoracotomy and nerve dissection have been previously reported 
in detail.9-11 In brief, thoracotomy was performed through the left 3rd intercostal space. 
The pericardium was opened to expose the left atrial appendage and the base of the 
LV. The LSG, vagal trunk, and left ansae subclaviae were identified (Figure 1A). After 
the left-sided procedure and protocol was completed, the wound was closed and a 
similar surgical procedure was performed on the right side via thoracotomy through the 
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right 3rd intercostal space. The right side of the SG (RSG), right vagal trunk, and right 
ansae subclaviae were then identified (Figure 1B). 
Experimental Procedure and Stimulation Sequence 
A standard Grass Stimulator (Grass Technologies) with a 10-Hz, 2-ms pulse 
duration and 10-V output was connected directly to the nervous structures via a pair of 
electrically active epicardial pacing suture wires. Before and after stimulation, 
electrophysiologic and hemodynamic measurements were recorded.  
The process of nerve dissection and stimulation is illustrated in Figure 2. The 
stimulation sequence included the initial stimulation of the intact LSG. Recordings were 
taken at baseline and 5 minutes after continuous stimulation. The left vagal trunk was 
stimulated next. Thereafter, the lower half of the LSG along with T2-T3 was resected. 
The stimulation wires were placed into the upper half of the LSG, and stimulation 
recordings were then performed. Subsequently, the left ansae subclaviae was severed, 
and we repeated our stimulation protocol. After this step, complete LSG dissection was 
performed and the stimulation wires were placed into ganglion chain just above SG and 
stimulated. Then the left-sided chest wound was closed, and the same process was 
repeated on the right side.  
Statistical Analyses 
All measurement data are expressed as mean (SD). Paired values before and 
after stimulations were compared using paired t tests. P values <.05 were considered 
statistically significant. All statistical analyses were performed using SPSS software 
(version 22.0, SPSS, Inc). 
Results 
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Baseline Stimulation of Left- and Right-Sided Nerves 
In dogs with an intact SG, the systolic and diastolic BP significantly increased 
during LSG stimulation (Table 1). We found an average increase from baseline of 49.4 
(26.6) mm Hg for systolic BP (P=.007) and 33.1 (18.9) mm Hg for diastolic BP (P=.008). 
Despite the increase in BP, the average heart rate did not change significantly (P=.35). 
In addition, no significant changes were seen in the atrial or ventricular (P=.09) ERPs, 
atrial conduction time, or other electrophysiologic parameters (Table 1).  
When the left vagal trunk was stimulated, the systolic BP decreased by 18.6 
(11.3) mm Hg from baseline, but this change was not statistically significant (P=.09). 
However, the diastolic BP significantly decreased by 11.8 (6.2) mm Hg (P=.002). 
Furthermore, the average HR decreased by 24 beats/min (P=.04) and atrial ERP was 
shortened by 17.6 (13.9) ms (P=.04) (Table 1). 
Stimulation of the RSG after removal of the LSG and the left ansae subclaviae 
led to significant increases in both systolic BP (by 34.0 (17.6) mm Hg; P=.005) and 
diastolic BP (by 13.0 (10.7) mm Hg; P=.005). The HR increased significantly by an 
average of 24 beats/min (P=.03), and the atrial ERP was significantly shortened, with an 
average decrease of 37.7 (5.5) ms (P=.001) (Table 1).  
When the right vagal trunk was stimulated, average HR decreased significantly, 
by 25.0 (10.2) beats/min (P=.04) (Table 1). The extent of HR reduction was not 
significantly different between the left and right vagal trunk stimulations (–29.0 [21.5] vs 
–25.0 [14.1] beats/min, respectively; P=.62). 
Effects of Stepwise Denervation 
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After resection of the lower half of the LSG, the systolic and diastolic BP were still 
susceptible to significant increase with stimulation, but to a lesser extent compared with 
the intact LSG (Table 2). The average increases in systolic and diastolic BP from before 
to after stimulation were 25.5 (14.1) mm Hg and 16.2 (11.8) mm Hg, respectively (both 
P=.02). No significant changes were noted in HR or other electrophysiologic parameters 
comparing prestimulation and poststimulation values.  
 After the left ansa subclavia was resected from the remaining LSG, the average 
poststimulation increase in systolic BP was 8.6 (3.4) mm Hg from pre stimulation 
(P=.047), and the increase in diastolic BP was 8.8 (3.9) mm Hg (P=.02). No significant 
changes were seen in HR or other electrophysiologic parameters (Table 2). After 
complete removal of the LSG and ansae subclaviae, there were no significant changes 
in HR, BP, QT interval, PR interval, R-R interval, atrial ERP, ventricular ERP, or left 
atrial conduction time compared with prestimulation values (Table 2). 
Effects of Stepwise Right Denervation  
After removal of the lower half of the RSG and ansae subclaviae, no significant 
changes in any hemodynamic or electrophysiologic parameters were noted by 
stimulating the upper RSG (Table 3). 
Comparing Magnitude of BP Effect after Stepwise Denervation 
We compared the delta values for change in systolic BP at each step in the 
denervation process and found that the extent of effect on BP by SG stimulation differed. 
In our left-sided denervation protocol, the mean (SD) change in systolic BP from pre 
stimulation to post stimulation of the LSG was 49.3 (18.9) mm Hg; it was 25.5 (9.5) mm 
Hg after dissecting the lower half of the LSG, 8.6 (8.0) mm Hg post denervation of the 
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left ansa subclavia, and 3.1 (2.9) mm Hg after total removal of the LSG. All delta values 
for systolic BP were significantly lower than in the previous step (Figure 3A). In the right-
sided denervation protocol, the mean delta values for systolic BP were 33.0 (12.1) mm 
Hg for the intact RSG, 13.8 (26.1) mm Hg after denervation of the lower RSG, 0.2 (14.5) 
mm Hg post denervation of the right ansa subclavia, and 3.25 (8.3) mm Hg after 
complete removal of the RSG (Figure 3B). 
Discussion 
Response to Stimulation of Thoracic Cardiac Nerves 
We found that stimulation of the left or right SG had significant effects on BP but 
no significant effects on the electrocardiographic conduction intervals, atrial and 
ventricular conduction times. In addition, right SG stimulation, but not left, increased HR. 
The increase in BP could be associated with an increase in cardiac contractile force 
and/or peripheral vascular resistance, as demonstrated in previous studies.12, 13  In 
those studies, stimulation of the LSG or RSG appears to induce positive inotropic 
changes and significantly increase intramyocardial pressure, systolic epicardial 
coronary venous pressure, and systolic coronary venous flow. Stimulation of the left 
ansa subclavia or ventrolateral nerve also resulted in a significant ventricular positive 
inotropic response. 
The magnitude of the increase in BP appears to be greater with LSG stimulation 
than RSG stimulation, consistent with the LSG being thought to dominate cardiac 
sympathetic control. Furthermore, the RSG has an independent effect on BP regulation 
after the LSG is completely resected. This observation is consistent with the previous 
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findings which demonstrated a similar increase in ventricular interstitial norepinephrine 
level by LSG or RSG stimulation. 14 15  
RSG stimulation increased HR, but LSG stimulation did not, which suggests that 
the RSG predominantly innervates the sinus node and thus affects HR regulation. 
Intuitively, the increase in BP by manipulation of the RSG could result from an 
increased positive inotropic force and/or increased HR. Both inotropic and chronotropic 
effects increase cardiac output and therefore, the BP. Ajijola et al16 reported a study on 
percutaneous stimulation of the lower LSG in humans. Similar to our study, they found 
that LSG stimulation did not affect HR but did increase BP and dP/dt max. They also 
found that the corrected QT interval and T-wave duration and amplitude were not 
changed significantly, findings that were echoed in our study. We found SG 
stimulation had a trend, but nonsignificant reduction in VERP, not consistent with 
previous reports. 6, 14, 17, 18 One explanation is the difference of our stimulation 
protocol and the site of stimulation from other studies. Alternatively, high 
background sympathetic tone of the experimental model associated with 
anesthesia and bilateral thoracotomy may mask the effect of SG stimulation on 
myocardial repolarization.   
Stimulation of either side of the vagal trunk decreases HR, a well-known 
physiologic effect. In our study, the extent of HR reduction appears to be similar 
between left and right vagal stimulation. This finding is consistent with results recently 
reported by Yamakawa et al.19   
Effects of Stepwise Sympathetic Denervation 
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We found a gradation in the extent of BP increase that occurred during 
stimulation of the SG after dissection of each of its components. The magnitude of BP 
increase was lessened, but still significant, after removing the lower half of the LSG 
down to the T3 level. Anatomically, as we directly observed, the ansae subclaviae 
directly connect between the upper part of the SG and the vagal trunk, as shown in 
Figure 1, or branch out, innervating the heart. They have a strong sympathetic output, 
as demonstrated by Norris et al.20  
We observed that the ansae subclaviae directly innervate the vagal trunk, as 
reported previously.18, 21, 22   Sheikh-Zade et al reported that in acute experiments on 
cats, stimulation of the ansae subclaviae potentiated the effects of vagal stimulation. 
The fibers of the ansae subclaviae that insert into the vagal trunk may affect vagal-
sympathetic interactions in the heart.23 After the ansae subclaviae were resected, a 
modest BP response remained. This may indicate that sympathetic fibers of the upper 
SG distribute to the myocardium via other potential connections, which can be a source 
of sympathetic-related arrhythmia after permanent SG-T4 denervation in patients with 
ventricular arrhythmia.  
Although right-sided SG stimulation increases BP, removal of the right lower SG 
appeared to eliminate the sympathetic effect on BP response. This differs from left-
sided SG denervation, in which the increase in BP remained until the entire SG and 
ansae subclaviae were removed. We could speculate that the right upper SG and ansae 
subclaviae have less control over the canine myocardium.  
We also found that the RSG had a significant and independent effect even after 
LSG denervation. The innervation of the LV from the RSG and the effects of the RSG 
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on cardiac arrhythmia are still controversial.14, 24 Previous studies have shown 
predominantly that the RSG innervates the anterior aspect of the ventricles, whereas 
the LSG predominantly affects the posterior aspect.17,25 The left-sided cardiac 
sympathetic innervations has been considered quantitatively dominant at the ventricular 
level as an arrhythmogenic source.26 However, recent studies have indicated that the 
RSG also has an important role in cardiac function. Opthof et al27 found significant inter-
animal variability in the average VF interval between local activations during SG 
stimulation and indicated that the LSG did not significantly innervate the anterior LV wall. 
Vaseghi et al14 found that both the LSG and RSG provided significant innervation to the 
anterior LV wall. These studies, as well as our data, suggest that bilateral sympathetic 
denervation may be required to reduce ventricular arrhythmia. 
Extent of SG Denervation and Clinical Implications 
Lower half LSG denervation has been shown to be effective in treating malignant 
ventricular arrhythmia in congenital long QT syndrome, catecholaminergic polymorphic 
VT, and acquired malignant ventricular arrhythmias with or without structural heart 
diseases.28-31 However, some patients still have recurrent arrhythmias after this 
procedure.32 33 Our findings suggest that sympathetic output remains effective even 
after the lower half LSG is removed. Left ansae subclaviae, and left upper SG maintains 
independent sympathetic effect, potentially responsible for sympathetic mediated VT/VF. 
The right SG is also an independent sympathetic target for treating drug-refractory 
VT/VF. These findings are supportive to the report from Vaseghi et al4 who found 
bilateral CSD to be more beneficial than left CSD alone.  
Study Limitations 
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Propofol was used as anesthetic in this study. Although propofol may have 
less of an impact on autonomic function compared to isoflurane, it is a cardio-
depressant, and its effects on hemodynamics may exist. We did stepwise 
dissection of different portion of SG. Yet the lower stellate ganglion, ansae 
subclaviae and upper stellate ganglion are not distinct entities and it is almost 
impossible to identify single structures and separate afferent and efferent fibers 
within the same structure. The RSG was stimulated only after LSG was 
completely resected. Thus, there was no direct comparison between intact LSG 
vs. intact RSG stimulation. This limitation may impact on the magnitude of effect 
on RSG stimulation. Finally, the study did not attempt to assess ventricular or 
atrial vulnerability by programmed electrical stimulation. The assessment of 
myocardial vulnerability could support the concept that lower stellate ganglion 
ablation only, as it is commonly performed in the clinical setting, may have 
important limitations on the effect of sympathetic denervation. 
Conclusions 
        Sympathetic output remains even after removal of the lower half of the LSG with 
intact ansa subclavia in dogs. This finding may partially explain some of the incomplete 
success in patients undergoing unilateral LSG denervation for treating ventricular 
arrhythmias. In addition, although the LSG has a dominant role in the autonomic control 
of cardiac physiology, the RSG seems to be an additional and independent sympathetic 
target for treating ventricular tachyarrhythmias.  
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Figure legends 
Figure 1. Anatomy of Stellate Ganglion, Vagal Trunk, and Ansae Subclaviae. 
 A, Left stellate ganglion (LSG), left vagal trunk, and left ansa subclavia. B, Right stellate ganglion (RSG), right vagal trunk, 
and right ansa subclavia. 
 
Figure 2. Illustration of Nerve Dissection and Stimulation.  
Left figure illustrates stellate ganglion (SG), T2 and Anca (ansa subclavian) connecting to the vagal nerve. ① indicates 
lower half SG, ② ansa subclavia, ③ upper half SG.  
Right figure shows removal of lower half SG (B), Anca (C) and upper half SG (D).  
The nerve dissection algorism is shown on the very right. 
 
Figure 3. Comparison of Change (Delta) in Systolic Blood Pressure (BPS) With Stepwise Denervation.  
A, Comparison of the delta value of BPS for left-sided stepwise denervation. Total stellate ganglion (SG) stimulation at 
baseline, then after the lower SG was cut, ansae subclaviae cut, and SG completely cut in stepwise manner; there was a 
gradation of effects on BPS. B, Comparison of the delta BPS for right-sided stepwise denervation. Only the second step, 
lower half SG cut had significant decrease in delta BPS. There were no significant differences between the latter 3 steps. 
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Table 1. Effects of Baseline Stimulationa  
Measure 
Left SG 
(n=8) 
Left Vagal Trunk 
(n=8) 
Right SG  
(n=6) 
Right Vagal Trunk 
(n=6) 
Pre stim Post stim Pre stim Post stim Pre stim Post stim Pre stim Post stim 
HR, beats/min 121.3 (16.1) 127.7 (14.1) 126.6 (11.2) 97.6 (25.3)b 125.2 
(11.2) 
149.2 
(17.7)b 
128.0 
(12.0) 
103.0 (23.0)b 
BPS, mm Hg 123.3 (22.2) 172.7 
(36.3)b 
131.3 (18.8) 112.5 (25.8) 117.7 
(24.3) 
150.7 
(33.7)c 
113.5 (18) 100.0 (21.7) 
BPD, mm Hg 72.9 (19.7) 106.0 
(16.0)b 
81.6 (11.8) 69.8 (9.2)c 74 (17.5) 87 (29.0)c 71.5 (7.18) 61.75 (9.0) 
AERP, ms 147.5 (19.8) 138.7 (19.6) 143.3 (17.5) 125.7 
(23.7)b 
161.7 
(17.2) 
134.0 
(19.5)c 
152.5 (15) 137.5 (37.7) 
VERP, ms 176.3 (14.1) 170.0 (15.1) 175.0 (10.5) 171.4 (9.0) 168.3 
(17.2) 
161.7 (14.7) 160.0 (8.2) 172.5 (29.9) 
R-R interval, ms 497.1 (63.4) 476.3 (46.5) 449.4 (50.6) 635.7 484.5 415.8 (62.5) 471.0 611.5 
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(288.0) (49.4) (33.5) (138.1) 
PR interval, ms 111.4 (14.8) 108.0 (18.2) 102.6 (16.1) 113.0 (36.0) 118 (12.6) 96.7 (26.2) 121.25 
(3.9) 
123.3 (16.0) 
QRS, ms 61.0 (4.5) 61.3 (4.6) 62.3 (50.2) 64.4 (8.8) 61.8 (4.6) 59.7 (5.5) 63 (8.6) 63 (7.0) 
QT interval, ms 254.0 (20.9) 242.9 (12.9) 243.1 (12.5) 257.1 (16.9) 250.7 
(24.1) 
235.3 (22.4) 237.5 (9.5) 253.5 (17.5)b 
LA conduction, 
ms 
25.6 (10.2) 24.0 (8.6) 22.4 (10.3) 23.7 (11.0) 25.2 (10.6) 21.7 (7.4) 32 (9.8) 24.5 (11.4) 
         
Abbreviations: AERP, atrial effective refractory period; BPD, diastolic blood pressure; BPS, systolic blood pressure; HR, 
heart rate; LA, left atrial; LV, left ventricular; SG, stellate ganglion; stim, stimulation; VERP, ventricular effective refractory 
period. 
a All values are mean (SD). 
b P<.05 vs prestimulation value. 
c P<.01 vs prestimulation value. 
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Table 2. Effects of Stepwise Left Sympathetic Denervationa 
 
 
 
 
Measure 
Lower Half SG Cut 
(n=7) 
Ansae Subclaviae Cut 
(n=5) 
SG Completely Cut 
(n=6) 
Pre stim Post stim Pre stim Post stim Pre stim Post stim 
HR, beats/min 121.7 (15.6) 122.9 (19.6) 126.4 (18.3) 129.4 (20.9) 130.6 (20.0) 135.2 (22.2)b 
BPS, mm Hg 113.5 (14.8) 139.0 (20.4)b 114.8 (16.0) 123.4 (18.7)b 115.5 (23.4) 118.6 (27.4) 
BPD, mm Hg 67.3 (13.2) 83.5 (19.0)b 68.2 (10.1) 77.0 (13.4)b 68.3 (18.9) 70.8 (19.5) 
AERP, ms 140.0 (12.6) 133.3 (12.1) 140.0 (10.0) 146.0 (13.4) 146.6 (16.3) 150.0 (12.2) 
VERP, ms 172.9 (13.8) 164.3 (7.9) 172.0 (8.4) 174.0 (13.4) 173.3 (8.2) 174.0 (5.5) 
R-R interval, ms 484.3 (73.1) 492.9 (75.7) 476.4 (78.3) 468.0 (80.3) 467.0 (70.4) 453.6 (77.3) 
PR interval, ms 109.3 (22.1) 106.5 (10.9) 113.0 (9.1) 112.8 (10.2) 112.0 (10.7) 113.6 (8.8) 
QRS, ms 60.9 (3.4) 58.4 (3.2) 60.6 (4.0) 65.2 (14.7) 61.7 (4.5) 57.6 (2.7)b 
QT interval, ms 246.0 (16.9) 236.8 (19.6) 241.8 (23.1) 242 (26.5) 240.8 (20.8) 239.8 (27.9) 
27 
LA conduction, 
ms 
24.9 (9.0) 20.7 (8.1) 25.6 (7.8) 25.2 (7.8) 26.3 (6.8) 26.4 (5.9) 
Abbreviations: AERP, atrial effective refractory period; BPD, diastolic blood pressure; BPS, systolic blood pressure; HR, 
heart rate; LA, left atrial; LV, left ventricular; SG, stellate ganglion; stim, stimulation; VERP, ventricular effective refractory 
period. 
a All values are mean (SD). 
b P<.05 vs prestimulation value.  
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Table 3. Effects of Stepwise Right Sympathetic Denervationa 
 
 
 
 
Measure 
Lower Half SG Cut 
(n=6) 
Ansae Subclaviae Cut 
(n=5) 
SG Completely Cut 
(n=5) 
Pre stim Post stim Pre stim Post stim Pre stim Post stim 
HR, beats/min 121.3 (7.6) 127.5 (25.6) 128.0 (6.7) 124.8 (10.3) 122.2 (14.7) 134.2 (12.8) 
BPS, mm Hg 103.7 (21.5) 116.7 (45.6) 107.2 (24.1) 107.0 (31.9) 109.0 (28.2) 121.3 (21.4) 
BPD, mm Hg 58.2 (18.4) 66.7 (28.7) 63.8 (17.3) 66.2 (26.1) 70.0 (18.2) 79.3 (12.6) 
AERP, ms 158.3 (19.4) 143.3 (24.2) 154.0 (19.5) 146.0 (26.1) 150.0 (26.5) 155.0 (12.9) 
VERP, ms 161.7 (13.3) 163.3 (29.4) 156.0 (11.4) 160.0 (18.7) 164.0 (19.5) 162.5 (20.6) 
R-R interval, ms 502.8 (35.1) 484.7 (96.7) 466.6 (30.5) 488.6 (47.9) 496.8 (65.0) 441.8 (51.0) 
PR interval, ms 119.3 (8.6) 103.3 (25.4) 115.0 (7.2) 116.4 (12.7) 127.2 (8.3) 113.8 (10.0) 
QRS, ms 61.2 (6.3) 58.5 (5.0) 62.6 (5.4) 61.2 (6.4) 59.2 (5.1) 59.3 (6.5) 
QT interval, ms 263 (27.0) 246.3 (29.2) 248.6 (9.6) 242.2 (24.5) 254.6 (30.0) 238.0 (13.4) 
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LA conduction, ms 25.2 (10.9) 22.3 (10.3) 29.0 (10.9) 28.0 (8.5) 26.4 (11.3) 28.3 (12.3) 
       
Abbreviations: AERP, atrial effective refractory period; BPD, diastolic blood pressure; BPS, systolic blood pressure; HR, 
heart rate; LA, left atrial; LV, left ventricular; SG, stellate ganglion; stim, stimulation; VERP, ventricular effective refractory 
period. 
a All values are mean (SD). 
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